Marijke C.M. Gordijn

Dr. Marijke C.M. Gordijn

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Applied Ergonomics
Verified
Journal Article
Closed access
VRVanessa Riethmeister
Vanessa Riethmeister
UBUte Bültmann
Ute Bültmann
MGMarijke C.M. Gordijn
Marijke C.M. Gordijn
SBSandra Brouwer
Sandra Brouwer
MBMichiel de Boer
Michiel de Boer

29 December 2022 in Biology
Verified
Journal Article
Open access
PDF file
MGMarina Cecilia Giménez
Marina Cecilia Giménez
MLMichelle Luxwolda
Michelle Luxwolda
ESEila Gesina van Stipriaan
Eila Gesina van Stipriaan
PBPauline P. Bollen
Pauline P. Bollen
RHRieks Hoekman
Rieks Hoekman
MGMarijke C.M. Gordijn
Marijke C.M. Gordijn
Modern urban human activities are largely restricted to the indoors, deprived of direct sunlight containing visible and near-infrared (NIR) wavelengths at high irradiance levels. Therapeutic exposure to doses of red and NIR, known as photobiomodulation (PBM), has been effective for a broad range of conditions. In a double-blind, randomized, placebo-controlled study, we aimed to assess the effects of a PBM home set-up on various aspects of well-being, health, sleep, and circadian rhythms in healthy human subjects with mild sleep complaints. The effects of three NIR light (850 nm) doses (1, 4, or 6.5 J·cm−2) were examined against the placebo. Exposure was presented five days per week between 9:30 am and 12:30 pm for four consecutive weeks. The study was conducted in both summer and winter to include seasonal variation. The results showed PBM treatment only at 6.5 J·cm−2 to have consistent positive benefits on well-being and health, specifically improving mood, reducing drowsiness, reducing IFN-γ, and resting heart rate. This was only observed in winter. No significant effects on sleep or circadian rhythms were noted. This study provides further evidence that adequate exposure to NIR, especially during low sunlight conditions, such as in the winter, can be beneficial for human health and wellness.

14 October 2025 in Trials
Verified
Journal Article
Open access
PDF file
EVEmma Visser
Emma Visser
ORO.G. Rus-Oswald
O.G. Rus-Oswald
ADA.J.W. van der Does
A.J.W. van der Does
MGMarijke C.M. Gordijn
Marijke C.M. Gordijn
MMM.C. Marcelis
M.C. Marcelis
NAN. Antypa
N. Antypa
Background: Bright Light Therapy (BLT) is an effective treatment for various mood disorders, but challenges remain in optimizing its real-world administration, predicting individual responses, and understanding its mechanisms. Methods: This multicenter randomized controlled trial will enroll 231 patients with unipolar or bipolar depression, all currently experiencing a depressive episode. Participants will be randomized to one of three BLT interventions: (1) traditional home-based BLT, (2) BLT administered in the LightCafé—a novel setting promoting social interaction and lifestyle support, or (3) LightCafé BLT with personalized timing of both light and darkness by adding the use of blue light blocking glasses. The treatment duration will range from one to three weeks, based on preset definitions of participant’s response. The primary outcome is the change in depressive symptoms, assessed by a blinded rater. Secondary outcomes include subjective and objective sleep measures, circadian rhythm parameters from melatonin patterns and actigraphy, and functional outcomes. Change processes will be assessed using ecological momentary assessments of daily affect and energy levels, light exposure sensors, and via brain imaging. Discussion: This trial is the first to directly compare different BLT administration models, including a LightCafé setting. It aims to identify predictors of BLT response, investigate chronobiological and neurobiological mechanisms, and provide insights to optimize BLT for diverse patient populations. The results will inform clinical guidelines and enhance BLT's accessibility and effectiveness. Trial registration: Registered on July 14, 2023, at clinicaltrials.gov under number NCT05958940.

2 September 2022 in Clocks & Sleep
Verified
Journal Article
Open access
PDF file
MGMarijke C.M. Gordijn
Marijke C.M. Gordijn
The 33rd annual meeting of the Society for Light Treatment and Biological Rhythms was held in Manchester in June 2022